Automation of High-Throughput Flow Cytometry
Historically, limited color detection, large sample volumes and manual loading were the reality of flow cytometers. Today however, flow cytometers can detect dozens of colors/markers simultaneously, saving precious samples and speeding up processing time.
Lateral Flow Assay Development Using Dyes Across the Spectrum
Download this whitepaper to discover assay development tools that can help you to image various dyes with different excitation and emission wavelengths, achieve a high degree of photostability as well as detect the presence of proteins including SARS-CoV-2's spike protein.
Non-Invasive Monitoring of Nonalcoholic Steatohepatitis
Nonalcoholic steatohepatitis (NASH) is an aggressive form of nonalcoholic fatty liver disease (NAFLD), a liver condition that is characterized by liver steatosis accompanied by liver cell injury and inflammation.
New for Old: The Value of Transitioning from qPCR to ddPCR
Droplet Digital PCR (ddPCR) is a refined form of digital PCR that offers a scalable and practical method for the absolute quantification of nucleic acids. 2021 marks ten years since the advent of ddPCR and in that time it has revolutionized discovery, development and quality control of biopharmaceuticals such as antibody-based biologics, vaccines, and cell and gene therapies.
Critical Parameters for Cleanroom Monitoring
Validation is an important process to ensure cleanrooms meet specific standards to be classified according to the International Standards Organization (ISO). ISO classifications ensure the integrity of the products, ranging from pharmaceuticals to semiconductors, contained in the cleanroom.
Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes
Download this whitepaper to uncover predicting disease onset via clinical biomarkers as well as other potential applications in diabetes research.
Confident RNA Sample Quality Control and Fragment Analysis.
This whitepaper, including 15 peer-reviewed publications across various RNA applications, demonstrates how researchers used automated electrophoresis for sample quality control and fragment analysis to ensure high-quality RNA and cDNA samples.
The Battle Against COVID-19
The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?
Can Your Clinical Diagnostics Contract Manufacturer Weather Supply Chain Challenges?
Supply chain security and transparency is a key part of the risk mitigation strategy of companies manufacturing clinical diagnostic assays. Prior to the COVID-19 crisis, complex global supply chains carefully balanced capacity with demand while cost-cutting initiatives pushed towards lower cost raw material providers located in different geographies.
Evolution in AAV Process Development: 2022 and Beyond
Over the last decade, the number of clinical trials involving recombinant adeno-associated viral (AAV) vectors has dramatically increased, the diversity of serotypes has expanded and the demand for larger quantities of highly purified material manufactured to cGMP standards has rocketed.